Back to search
FDAFDA · Food and drugs·Recall number D-1056-2017

Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60

Published August 9, 2017 · Recall initiated: July 24, 2017

Summary

FDA records drug Class II recall D-1056-2017, published August 9, 2017 and initiated July 24, 2017. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 28,188 bottles; Lot: Lot # 3429066, exp 06/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specification; out of specification for tablet weight

What to do

Voluntary: Firm initiated · Letter

Get an email if FAMOTIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FAMOTIDINE
Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide
Lot
Lot # 3429066, exp 06/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60 recalled?

Yes. FDA published recall D-1056-2017 on August 9, 2017. Reported hazard: Failed Tablet/Capsule Specification; out of specification for tablet weight

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FAMOTIDINE.